Results 51 to 60 of about 53,297 (154)
Additional file 4. List of the abbreviations of brain regions used in the figures.
Rey, Nolwen +8 more
openaire +1 more source
Design, Synthesis and Biological Evaluation of α-Synuclein Proteolysis-Targeting Chimeras
α-Synuclein aggregation under pathological conditions is one of the causes of related neurodegenerative diseases. PROTACs (proteolysis targeting chimeras) are bifunctional small molecules that induce a post-translational erasure of proteins via the ...
Tianzhi Wen +3 more
doaj +1 more source
Additional file 3. Examples of pser129-positive inclusions at high and low magnifications.
Rey, Nolwen +8 more
openaire +1 more source
Clinical Neuropathology image 5-2014: α-synuclein pathology in the ependyma in Parkinsonâs disease [PDF]
Not available.
openaire +2 more sources
Additional file 1. Quality control of the assemblies.
Rey, Nolwen +8 more
openaire +1 more source
The activation of microglial NADPH oxidase (NOX2) induced by α-synuclein has been implicated in Parkinson's disease (PD) and other synucleinopathies. However, how α-synuclein activates NOX2 remains unclear. Previous study revealed that both toll-like receptor 2 (TLR2) and integrin play important roles in α-synuclein-induced microglial activation.
Liyan Hou +9 more
openaire +3 more sources
Materials and Methods. Table S1. Raw data of qPCR analysis (average Cq value). Figure S1. Immunohistochemical images used for quantitative analysis in this study. (DOCX 25253 kb)
Hagihara, Hideo +4 more
openaire +1 more source
α-Synuclein pathology from the body to the brain: so many seeds so close to the central soil
α-Synuclein is a protein that mainly exists in the presynaptic terminals. Abnormal folding and accumulation of α-synuclein are found in several neurodegenerative diseases, including Parkinson’s disease.
Yunying Yang, Zhentao Zhang
doaj +1 more source
Synucleinopathies such as Parkinson's disease, multiple system atrophy and dementia with Lewy bodies are characterized by deposition of aggregated α-synuclein. Recent findings indicate that pathological oligomers rather than fibrillar aggregates may represent the main toxic protein species.
Schmidt, Felix +5 more
openaire +7 more sources
Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang +2 more
wiley +1 more source

